Robotic Transabdominal Specimen Extraction vs Transanal Specimen Extraction for Sigmoid and Upper Rectal Cancer: A Comparative Analysis of Short-term Outcomes
This retrospective study demonstrates that robotic transanal specimen extraction (NOSES-IV) offers superior short-term outcomes, including reduced pain, fewer incisional complications, and faster recovery, compared to robotic transabdominal extraction for patients with sigmoid and upper rectal cancer.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Colorectal cancer, a disease that affects the large intestine and rectum, remains one of the most common and serious health challenges worldwide. When surgery is required to remove the tumor, the goal is always to take out the diseased tissue completely while causing as little disruption to the patient's body as possible. For decades, surgeons have relied on making small cuts in the abdomen to perform these operations, but a newer approach seeks to avoid cutting the abdominal wall entirely for the final step of removing the tumor. This method, known as natural orifice specimen extraction, involves pulling the removed tissue out through the anus, leaving the belly skin untouched. At the same time, many hospitals have adopted robotic surgical systems, which use computer-controlled arms to give surgeons greater precision and stability, especially in the tight space of the pelvis. The question facing modern medicine is whether combining these two advanced techniques—using a robot to perform the surgery and pulling the tumor out through the natural opening—offers a better recovery for patients than the traditional method of making a small incision in the lower abdomen to remove the specimen.
Researchers at the First Affiliated Hospital of Jiangxi Medical College in Nanchang, China, set out to answer this question by looking back at the records of 254 patients who underwent robotic surgery for sigmoid colon or upper rectal cancer between January 2019 and January 2026. They divided these patients into two groups based on how the tumor was removed. One group, consisting of 91 patients, had their tumors extracted through the anus, a technique called NOSES-IV. The other group, with 163 patients, had their tumors removed through a small incision in the lower abdomen, known as transabdominal specimen extraction, or TASE. To ensure a fair comparison, the researchers used a statistical method to match patients in both groups so that factors like age, body size, and the specific location of the tumor were nearly identical. This left them with 83 matched pairs to analyze closely, allowing them to see if the difference in the extraction method truly changed the outcome.
The results showed that the robotic approach using the natural opening provided a smoother recovery for the patients. While the total time the surgeons spent in the operating room was similar for both groups, the time required to rebuild the connection between the healthy parts of the intestine was significantly shorter for the group that had the tumor pulled out through the anus. These patients also lost less blood during the procedure. More importantly, the recovery after surgery was faster for the natural opening group. They were able to get out of bed and walk sooner, pass gas to indicate their bowels were working again, and start eating solid food earlier than those who had the abdominal incision. On the third and fifth days after surgery, their levels of C-reactive protein, a marker that indicates inflammation in the body, were lower, suggesting their bodies were under less stress. They also reported less pain on a standard pain scale.
Safety was a major focus of the study, and the data indicated that the natural opening method was not only effective but also safer regarding the surgical wound. None of the patients in the group that avoided the abdominal cut developed complications related to the incision, such as infections or fat liquefaction. In contrast, seven patients in the group with the abdominal incision experienced these specific wound issues. The rates of other serious complications, such as leaks at the connection site or pneumonia, were similar between the two groups, and no patients died from the procedure in either category. The study also confirmed that the new method did not harm the function of the anus; three months after surgery, the ability to control bowel movements was the same for both groups. The researchers noted that the benefits of the natural opening technique were most apparent when the patient's anatomy and the tumor's size were suitable for the procedure.
Ultimately, this study suggests that for carefully selected patients with sigmoid colon or upper rectal cancer, using a robot to remove the tumor through the anus is a safe and viable option that offers a quicker and less painful recovery than removing it through a small cut in the abdomen. By avoiding an extra incision, patients experienced fewer wound complications and returned to their normal activities faster. The authors emphasize that while these short-term results are promising, the technique requires specific patient criteria to be successful, and further studies are needed to confirm these findings across a wider population. For now, the data provides strong evidence that minimizing the physical trauma of the surgery itself can lead to a gentler path back to health.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.